Literature DB >> 7589041

Pressor, renal and endocrine effects of L-arginine in essential hypertensives.

R Pedrinelli1, M Ebel, G Catapano, G Dell'Omo, M Ducci, M Del Chicca, A Clerico.   

Abstract

The pressor, renal and endocrine effect of the physiological precursor of endothelial derived nitric oxide, L-arginine was compared, with a substrate inactive on nitric oxide, hypertonic D-glucose, in hypertensive patients. Ten mild-moderate essential hypertensives were assigned to either L-arginine (n = 5) or D-glucose (n = 5). Substances were infused over 25 min at equiosmolal rates preceded and followed by saline infusion for 25 min. Blood pressure and heart rate were monitored at 3-min intervals, while hormonal and humoral variables, inulin and paraaminohippurate clearance and electrolyte excretion were measured at the end of each period under conditions of maximal diuresis. L-arginine and D-glucose increased serum osmolality comparably and caused similar haemodilution to that with control saline. During L-arginine infusion, systolic and diastolic blood pressure decreased by 16.6% and 11%, respectively, and recovered in the postinfusion period. Heart rate, plasma renin activity, and plasma noradrenaline did not change significantly. The percent blood pressure decrement induced by L-arginine was significantly greater than that by D-glucose. Glomerular filtration rate was stable and renal plasma flow was increased by both substances. However, natriuresis, kaliuresis and chloruresis were markedly stimulated only by L-arginine, which also promoted the development of systemic acidosis, possibly as a consequence of hydrochloridric acid generated during its metabolism. Circulating insulin, atrial natriuretic peptide, growth hormone and glucagon levels were increased and plasma aldosterone was unchanged during infusion of L-arginine. Insulin was stimulated and the other hormones inhibited during infusion of D-glucose.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589041     DOI: 10.1007/BF00198298

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

1.  Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings.

Authors:  C Berne; J Fagius; F Niklasson
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

2.  L-arginine-induced hypotension.

Authors:  T Nakaki; K Hishikawa; H Suzuki; T Saruta; R Kato
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

3.  Measurement of plasma renin activity by angiotensin I radioimmunoassay: (I) an assessment of some methodological aspects.

Authors:  R Malvano; G C Zucchelli; U Rosa; A Salvetti
Journal:  J Nucl Biol Med       Date:  1972 Jan-Mar

4.  The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis.

Authors:  D C Batlle; M Hizon; E Cohen; C Gutterman; R Gupta
Journal:  N Engl J Med       Date:  1988-03-10       Impact factor: 91.245

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

Authors:  J A Panza; P R Casino; D M Badar; A A Quyyumi
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

7.  Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.

Authors:  J Mulvihill-Wilson; F A Gaffney; W A Pettinger; C G Blomqvist; S Anderson; R M Graham
Journal:  Circulation       Date:  1983-02       Impact factor: 29.690

8.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Authors:  M A Creager; S J Gallagher; X J Girerd; S M Coleman; V J Dzau; J P Cooke
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Analgesic effect of L-arginine in patients with persistent pain.

Authors:  A Harima; H Shimizu; H Takagi
Journal:  Eur Neuropsychopharmacol       Date:  1991-12       Impact factor: 4.600

10.  Low dose atrial natriuretic factor in primary aldosteronism: renal, hemodynamic, and vascular effects.

Authors:  R Pedrinelli; G Panarace; M Spessot; S Taddei; S Favilla; L Graziadei; A Lucarini; A Salvetti
Journal:  Hypertension       Date:  1989-08       Impact factor: 10.190

View more
  3 in total

1.  Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats.

Authors:  Fumio Ohta; Tomo Takagi; Hiroyuki Sato; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

2.  Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man.

Authors:  M Maccario; S E Oleandri; M Procopio; S Grottoli; E Avogadri; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

Review 3.  Acute and chronic endothelial dysfunction: implications for the development of heart failure.

Authors:  Axel Linke; Fabio Recchia; Xiaoping Zhang; Thomas H Hintze
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.